The First Hospital Of Jilin University
Clinical trials sponsored by The First Hospital Of Jilin University, explained in plain language.
-
New hope for advanced colon cancer: drug combo trial opens
Disease control Recruiting nowThis study tests a new combination of drugs for people with advanced colorectal cancer that has stopped responding to initial treatment. About 30 adults aged 18-75 will receive a mix of chemotherapy and targeted therapy. The goal is to see if this approach can delay cancer growth…
Phase: PHASE2 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Supercharged immune cells take on Hard-to-Treat blood cancer
Disease control Recruiting nowThis study tests a new type of CAR-T cell therapy, boosted with IL-15, in 25 people with multiple myeloma or plasma cell leukemia that has come back or not responded to treatment. The therapy uses the patient's own immune cells, engineered to target cancer cells. The goal is to s…
Phase: PHASE2 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New combo therapy aims to shrink tough rectal cancers before surgery
Disease control Recruiting nowThis study tests whether adding a targeted drug (surufatinib) to a standard pre-surgery regimen of short-course radiation, chemotherapy, and immunotherapy (toripalimab) can improve outcomes for people with high-risk mid-to-low rectal cancer. About 212 participants will receive on…
Phase: PHASE2, PHASE3 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New hope for hard-to-treat ovarian cancer: combo therapy enters human trial
Disease control Recruiting nowThis study tests a new drug called CapsuleX combined with cisplatin in 40 people whose ovarian cancer no longer responds to platinum-based chemotherapy. The goal is to see if the combination can shrink tumors and how safe it is. Participants must have confirmed ovarian, fallopian…
Phase: NA • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Plant extract shows promise in ovarian cancer maintenance trial
Disease control Recruiting nowThis study tests whether daphnetin capsules, made from a daphne plant extract, can improve outcomes when combined with standard chemotherapy (TC regimen) for stage III-IV epithelial ovarian cancer. About 98 participants who had initial surgery will receive the combination, then c…
Phase: NA • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New surgery may help rectal cancer patients avoid permanent stoma
Disease control Recruiting nowThis study tests whether a special delayed-connection surgery (Turnbull-Cutait) can help people with low rectal cancer avoid a permanent colostomy bag better than the standard surgery with a temporary stoma. About 520 adults aged 18-75 with rectal cancer will be randomly assigned…
Phase: NA • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a cervical liquid zap persistent HPV? new trial aims to find out
Disease control Recruiting nowThis study is testing whether a liquid called Paiteling, applied directly to the cervix, can clear persistent high-risk HPV infections. The trial will enroll 115 women aged 25 to 65 who have had the same high-risk HPV type for at least two years. Researchers will check if the vir…
Phase: PHASE4 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Promising combo may keep rare melanoma at bay
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug sintilimab to standard chemotherapy can help prevent a rare type of skin cancer (mucosal melanoma) from coming back after surgery. About 220 adults with PD-L1-positive, completely removed tumors will be randomly assigned to g…
Phase: PHASE2 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could a quick second drug boost stroke recovery?
Disease control Recruiting nowThis study tests whether giving the blood thinner tirofiban soon after standard clot-busting medication helps people recover better from a stroke. About 1,084 adults with moderate stroke symptoms will receive either tirofiban or a placebo within 6 hours of the initial treatment. …
Phase: NA • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
AI takes on diabetes: could a smartphone app beat standard care?
Disease control Recruiting nowThis study tests whether an artificial intelligence (AI) smartphone app can help people with type 2 diabetes control their blood sugar better than regular doctor visits. About 400 adults will either use the AI app to get personalized diet, exercise, and medication advice, or rece…
Phase: NA • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug cocktail aims to slow kidney disease in IgA patients
Disease control Recruiting nowThis study tests whether combining budesonide (Nefecon) and ambrisentan can reduce protein in the urine and preserve kidney function in people with IgA nephropathy who are at risk of kidney failure. About 129 adults will take both pills daily for 36 weeks. Researchers will measur…
Phase: PHASE4 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 26, 2026 17:13 UTC
-
New ultrasound technique could spot deadly varices without a scope
Diagnosis Recruiting nowThis study is testing a new, non-invasive way to detect high-risk varices (enlarged veins) in the esophagus and stomach of people with liver cirrhosis. Instead of using a camera down the throat (endoscopy), doctors will use a special ultrasound technique called SHAPE, along with …
Phase: NA • Sponsor: The First Hospital of Jilin University • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Can we predict hidden polyps in kidney stone patients?
Knowledge-focused Recruiting nowThis study is looking for factors that might predict inflammatory polyps in the ureter (the tube from kidney to bladder) in people with kidney stones. Researchers will review past patient data and then test their predictions on new patients. The goal is to create a simple tool th…
Sponsor: The First Hospital of Jilin University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
AI may predict dangerous clots after lung cancer surgery
Knowledge-focused Recruiting nowThis study follows 900 people having lung cancer surgery to learn why some develop blood clots in their legs (deep vein thrombosis) within 30 days after surgery. Researchers will collect medical data and use machine learning to build a tool that predicts each person's risk. The g…
Sponsor: The First Hospital of Jilin University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Blood particle study could reveal new clues for aneurysm diagnosis
Knowledge-focused Recruiting nowThis observational study looks at proteins in tiny particles called extracellular vesicles from the blood of 120 people with brain aneurysms. Researchers will collect blood from different areas of the circulatory system during surgery to compare protein patterns. The goal is to f…
Sponsor: The First Hospital of Jilin University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Less food before flip: could cutting tube feedings prevent stomach issues in ICU patients?
Knowledge-focused Recruiting nowThis study looks at whether lowering the amount of liquid food given through a tube before turning a patient onto their stomach (prone position) can reduce stomach problems like bloating or vomiting. The study involves 259 adults in the ICU who are on breathing machines for sever…
Phase: NA • Sponsor: The First Hospital of Jilin University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC